ACE Report Cover
Osteoporotic fracture rate not significantly improved by vitamin B-12 or folic acid intake
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
METABOLIC DISORDERS
Osteoporotic fracture rate not significantly improved by vitamin B-12 or folic acid intake .
Verified
This report has been verified by one or more authors of the original publication.
High Impact
This study has been identified as potentially high impact. OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself. Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone. This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.

Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial.

Am J Clin Nutr. 2014 Dec;100(6):1578-86.

2919 elderly hyperhomocysteinemic patients at risk for osteoporotic fractures were randomized to receive daily oral supplements containing 500 mg vitamin B-12, 400 mg folic acid and 600 IU of vitamin D3 or a placebo supplement containing only vitamin D3. The purpose of this study was to investigate whether the intake of vitamin B-12 and folic acid impacted the time to first osteoporotic fracture and if adverse events occurred from its consumption. The results indicated that there was no significant difference in the time to first osteoporotic fracture occurrence between the two groups. Compliant patients over 80, however, displayed an improved fracture rate when compared to placebo. It was also noted that but the supplement-receiving group had a greater incidence of cancer development during the course of the trial, however, further studies are needed to evaluate the effect of these supplements on cancer incidence.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Osteoporotic fracture rate not significantly improved by vitamin B-12 or folic acid intake. ACE Report. 2015;4(3):24. Available from: https://myorthoevidence.com/AceReport/Show/osteoporotic-fracture-rate-not-significantly-improved-by-vitamin-b-12-or-folic-acid-intake

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report